The essentials of essential fatty acids

Journal of Dietary Supplements

Volumn 6, Issue 2, 2009, Pages 143-161

  Di Pasquale, Mauro G ^a  

^a NONE   (Canada)

Author keywords

Body composition; EFA deficiency; EFA supplementation; Essential fatty acids; Exercise performance

Indexed keywords

ESSENTIAL FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ARTICLE; DIET; FAT INTAKE; HUMAN; NUTRITIONAL REQUIREMENT;

DIET; DIETARY FATS; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; NUTRITIONAL REQUIREMENTS;

EID: 67650673851     PISSN: 19390211     EISSN: None     Source Type: Journal    
DOI: 10.1080/19390210902861841     Document Type: Article

References (136)

1. Adam O, Beringer C, Kless T, Lemmen C, Adam A, Wiseman M, Adam P, Klimmek R, Forth W. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int. 2003;23:27-36.
2. Aldámiz-EchevarrÍa L, Bilbao A, Andrade F, Elorz J, Prieto JA, Rodriguez-Soriano J. Fatty acid deficiency profile in children with food allergy managed with elimination diets. Acta Paediatr. 2008;97(11): 1572-1576.
3. Aldámiz-EchevarrÍa L, Vallo A, Aguirre M, Sanjurjo P, Gonzalez-LamuŃo D, Elorz J, Prieto JA, Andrade F, Rodriguez-Soriano J. Essential fatty acid deficiency profile in patients with nephrotic-range proteinuria. Pediatr Nephrol. 2007;22(4):533-540.
4. Alexander JW, Saito H, Trocki O, Ogle CK. The importance of lipid type in the diet after burn injury. Ann Surg. 1986;204:1-8.
5. Anon. Folic acid. Good for brain health. Mayo Clin Health Lett. 2007;25(7):6.
6. Antypa N, Van der Does A, Smelt A, Rogers R. Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. J Psychopharmacol. [Epub 2008 Nov 21].
7. Astorg P, Arnault N, Czernichow S, Noisette N, Galan P, Hercberg S. Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids. 2004;39(6):527-535.
8. Awad AB, Zepp EA. Alteration of rat adipose tissue lipolytic response to norepinephrine by dietary fatty acid manipulation. Biochem Biophys Res Comm. 1979;86:138-144.
9. Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E sub 2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983;308:553-558.
10. Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr. 2000;130(8):1925-1931.
11. Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani G, Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr. 2000;71S:339S-342S.
12. Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr. 2002;22:505-531.
13. Belzung F, Raclot T, Groscolas R. Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing fats fed high-fat diets. Am J Physiol. 1993;264(6Pt2):Rllll-R1118.
14. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006;17(12):789-810.
15. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000;130:2943-2948.
16. Bourre JM. Dietary omega-3 fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. J Nutr Health Aging. 2005;9(l):31-38.
17. Carrero JJ, Fonolla J, Marti JL, Jimenez J, Boza JJ, Lopez-Huertas E. Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J Nutr. 2007;137(2):384-390.
18. Cheng WL, Lii CK, Chen HW, Lin TH, Liu KL. Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-kappaB pathway. J Agric Food Chem. 2004;52(l):71-78.
19. Choi Y, Kim YC, Han YB, Park Y, Pariza MW, Ntambi JM. The trans-10,cis-12 isomer of conjugated linoleic acid down regulates stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes, J Nutr. 2000;130(8):1920-1924.
20. Chung H, Nettleton JA, Lemaitre RN, Barr RG, Tsai MY, Tracy RP, Siscovick DS. Frequency and type of seafood consumed influence plasma (n-3) fatty acid concentrations. J Nutr. 2008;138(12):2422-2427.
21. Close RN, Schoeller DA, Watras AC, Nora EH. Conjugated linoleic acid supplementation alters the 6-mo change in fat oxidation during sleep. Am J Clin Nutr. 2007;86(3):797-804.
22. Cook ME, Miller CC, Park Y, Pariza M. Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression. Poult Sci. 1993;72(7):1301-1305.
23. Crawford MA. Fatty acids in free-living and domestic animals. Lancet. 1968;1:1329-1333.
24. Cundiff DK, Lanou AJ, Nigg CR. Relation of omega-3 fatty acid intake to other dietary factors known to reduce coronary heart disease risk. Am J Cardiol. 2007;99(9):1230-1233.
25. da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. J Affect Disord. 2008;111(2-3):351-359.
26. Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, antihypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis. 2008;7:37. [Epub ahead of print].
27. DeLany JP, Blohm F, Truett AA, Scimeca JA, West DB. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol. 1999;276:R1172-R1179.
28. Delarue J, LeFoll C, Corporeau C, Lucas D. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev. 2004;44(3):289-299.
29. DeLuca P, Rossetti RG, Alavian C, Karim P, Zurier RB. Effects of gamma-linolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo. J Investig Med. 1999;47(5):246-250.
30. Dray F, Kouznetzova B, Harris D, Brazeau P. Role of prostaglandins on growth hormone secretion: PGE2 a physiological stimulator. Adv Prostaglandin Thromboxane Res. 1980;8:1321-1328.
31. Eder K, Schleser S, Becker K, Korting R. Conjugated linoleic acids lower the release of eicosanoids and nitric oxide from human aortic endothelial cells. J Nutr. 2003;133:4083-4089.
32. Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. BiochimBiophys Acta. 1994;1213(3):277-288.
33. Emsley R, Myburgh C, Oosthuizen P, van Rensburg SJ. Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry. 2002;159(9):1596-1598.
34. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989;320:265-271.
35. Esperson GT, Grunnet N, Lervang HH, Nielsen GL, Thomsen BS, Faarvang KL, Dyerberg J, Ernst E. Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin Rheumatol. 1992;11:393-395.
36. Eyjolfson V, Spriet LL, Dyck DJ. Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc. 2004;36(5):814-820.
37. Fan YY, Chapkin RS. Importance of dietary gamma-linolenic acid in human health and nutrition. J Nutr. 1998;128(9):1411-1414.
38. Farrell DJ. Enrichment of hen eggs with n-3 long-chain fatty acids and evaluation of enriched eggs in humans. Am J Clin Nutr. 1998;68(3):538-544.
39. Ferrier LK, Caston LJ, Leeson S, Squires J, Weaver BJ, Holub BJ. alpha-Linolenic acid-and docosahexaenoic acid-enriched eggs from hens fed flaxseed: influence on blood lipids and platelet phospholipid fatty acids in humans. Am J Clin Nutr. 1995;62(l):81-86.
40. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Franssen-van Hal N, Ruzickova J, Sponarova J, Drahota Z, Vlcek C, Keijer J, Houstek J, Kopecky J. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia. 2005;48(ll):2365-2375.
41. Flachs P, Rossmeisl M, Bryhn M, Kopecky J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond). 2009;116(1):1-16.
42. Furse RK, Rossetti RG, Seiler CM, Zurier RB. Oral administration of gamma-linolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates vinterleukin-lbeta production by human monocytes. J Clin Immunol. 2002;22(2):83-91.
43. Gariballa S, Forster S. Effects of dietary supplements on depressive symptoms in older patients: a randomised double-blind placebo-controlled trial. Clin Nutr. 2007;26(5):545-551. [Epub ahead of print].
44. Gaullier JM, Halse J, Hoivik HO, Hoye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. Br J Nutr. 2007;97(3):550-560.
45. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr. 2005;135(4):778-784.
46. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr. 2004;79(6):1118-1125.
47. Gillis RC, Daley BJ, Enderson BL, Karlstad MD. Eicosapentaenoic acid and gamma-linolenic acid induce apoptosis in HL-60 cells. J Surg Res. 2002;107(1):145-153.
48. Goodnight SH, Harris WS, Connor WE, Illingworth DR. Polyunsaturated fatty acids, hyperlipidemia and thrombosis. Arteriosclerosis. 1982;2:87-111.
49. Gueck T, Seidel A, Baumann D, Meister A, Fuhrmann H. Alterations of mast cell mediator production and release by gamma-linolenic and docosahexaenoic acid. Vet Dermatol. 2004;15(5):309̃314.
50. Hallahan B, Garland MR. Essential fatty acids and mental health. Br J Psychiatry. 2005;186:275-277.
51. Hardman WE. (n-3) fatty acids and cancer therapy. J Nutr. 2004; 134(12 Suppl):3427S-3430S.
52. Herold PM, Kinsella JE. Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials. Am J Clin Nutr. 1986;43:566-598.
53. Hibbeln JR. Depression, suicide and deficiencies of omega-3 essential Fatty acids in modern diets. World Rev Nutr Diet. 2009;99:17-30.
54. Hibbeln JR, Nieminen LR, Lands WE. Increasing homicide rates and linoleic acid consumption among five Western countries, 1961-2000. Lipids. 2004;39(12):1207-1213.
55. Hill TM, Bateman HG 2nd, Aldrich JM, Schlotterbeck RL. Effects of changing the essential and functional fatty acid intake of dairy calves. J Dairy Sci. 2009;92(2):670-676.
56. Hjerkinn EM, Seljeflot I, Ellingsen I, Berstad P, Hjermann I, Sandvik L, Arnesen H. Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr. 2005;81(3):583-589.
57. Hodgson JM, Wahlqvist ML, Boxall JA, Balazs ND. Can linoleic acid contribute to coronary artery disease? Am J Clin Nutr. 1993;58(2):228-234.
58. Hogstrom M, Nordstrom P, Nordstrom A. n-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the N02 Study. Am J Clin Nutr. 2007;85(3):803-807.
59. Hosli I, Zanetti-Daellenbach R, Holzgreve W, Lapaire O. Role of omega 3-fatty acids and multivitamins in gestation. J Perinat Med. 2007;35(Suppl 1):S19-S24.
60. Houston MC. Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals. Expert Rev Cardiovasc Ther. 2007;5(4):681-691.
61. Hu J, Morrison H, Mery L, DesMeules M, Macleod M, Canadian Cancer Registries Epidemiology Research Group. Diet and vitamin or mineral supplementation and risk of colon cancer by subsite in Canada. Eur J Cancer Prev. 2007;16(4):275-291.
62. Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Etherton TD. Kris-Etherton PM, Taylor DS, Yu-Poth S. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000;71(1 Suppl):179S-188S.
63. Ian Givens D, Gibbs RA. Current intakes of EPA and DHA in European populations and the potential of animal-derived foods to increase them. Proc Nutr Soc. 2008;67(3):273-280. [Epub 2008 May 23].
64. Indu M, Ghafoorunissa. N-3 fatty acids in Indian diets-comparison of the effects of precursor (alpha-linolenic acid) vs product (long chain n-3 polyunsaturated fatty acids). Nutr Res. 1992;12:569-582.
65. Ip C, Scimeca JA, Thompson HJ. Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources [Review]. Cancer. 1994;74(3 Suppl): 1050-1054.
66. Ip C, Singh M, Thompson HJ, Scimeca JA. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 1994;54(5):1212-1215.
67. Ismail HM. The role of omega-3 fatty acids in cardiac protection: an overview. Front Biosci. 2005;10:1079-1088.
68. Jacobson TA. Beyond lipids: the role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease. Curr Atheroscler Rep. 2007;9(2): 145-153.
69. Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton FH. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997; 127(8): 1435-1444.
70. Kapoor R, Huang YS. Gamma linolenic acid: an antiinflammatory omega-6 fatty acid. Curr Pharm Biotechnol. 2006;7(6):531-534.
71. Kelley VE, Ferretti A, Izui S, Strom TB. A fish oil diet rich in eicosapentaenoic acid reduces cyclo oxygenase metabolites and supresses lupus in MRL-lpr mice. J Immunol. 1985;134:1914-1919.
72. Kelley DS, Siegel D, Fedor DM, Adkins Y, Mackey BE. DHA supplementation decreases Serum C-reactive protein and other markers of inflammation in hyper-triglyceridemic men. J Nutr. 2009;139(3):495-501.
73. Kremer JM, Bigauoette J, Michalek AV, Timchalk MA, Lininger L, Rynes RI, Huyck C, Zieminski J, Bartholomew LE. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1985;1:184-187.
74. Kremer JM, Lawrence DA, Petrillo GF, Litts LL, Mullaly PM, Rynes RI, Stocker RP, Parhami N, Greenstein NS, Fuchs BR. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates. Arthritis Rheum. 1995;38:1107-1114.
75. Leaf A. Historical overview of n-3 fatty acids and coronary heart disease. Am J Clin Nutr. 2008;87(6):1978S-1980S.
76. Lewis NM, Seburg S, Flanagan NL. Enriched eggs as a source of N-3 polyunsaturated fatty acids for humans. Poult Sci. 2000;79(7):971-974.
77. Lovegrove JA, Brooks CN, Murphy MC, Gould BJ, Williams CM. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake. Br J Nutr. 1997;78(2):223-236.
78. Luongo D, Bergamo P, Rossi M. Effects of conjugated linoleic acid on growth and cytokine expression in Jurkat T cells. Immunol Lett. 2003;90:195-201.
79. Machefer G, Groussard C, Vincent S, Zouhal H, Faure H, Cillard J, Radak Z, Gratas-Delamarche A. Multivitamin-mineral supplementation prevents lipid peroxidation during "the Marathon des Sables." J Am Coll Nutr. 2007;26(2):111-120.
80. Maclean CH, Issa AM, Newberry SJ, Mojica WA, Morton SC, Garland RH, Hilton LG, Traina SB, Shekelle PG. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. Evid Rep Technol Assess (Summ). 2005;(114):l-3.
81. Manhezi AC, Bachion MM, Pereira AL. The use of essential fatty acids in the treatments of wounds. Rev Bras Enferm. 2008;61(5):620-628.
82. Metcalf RG, James MJ, Mantzioris E, Cleland LG. A practical approach to increasing intakes of n-3 polyunsaturated fatty acids: use of novel foods enriched with n-3 fats. Eur J Clin Nutr. 2003;57(12):1605-1612.
83. Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PR. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids. 2003;38(4):391-398.
84. Miller CC, Park Y, Pariza MW, Cook ME. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem BiophysicRes Comm. 1994;198(3):1107-1112.
85. Mori TA, Beilin U. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep. 2004;6(6):461-467.
86. Mori TA, Puddey IB, Burke V, Croft KD, Dunstan DW, Rivera JH, Beilin LJ. Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Redox Rep. 2000;5(l):45-46.
87. Mosley BS, Hobbs CA, Flowers BS, Smith V, Robbins JM. Folic acid and the decline in neural tube defects in Arkansas. J Ark Med Soc. 2007;103(10):247-250.
88. Needleman P, Raz M, Minkes MS, Ferrendelli JA, Sprecher H. Triene prostaglandins: prostaglandin and thromboxane biosynthesis and unique biologic properties. Proc Natl Acad Sci. 1979;76:944-948.
89. Nettleton JA, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc. 2005;105(3):428-440.
90. Nykamp D, Kavanaugh ED, Wenker AP. Vitamins: the wise choice for women with cardiovascular disease. Consult Pharm. 2007;22(6):490-502.
91. Obata T, Nagakura T, Masaki T, Maekawa K, Yamashita K. Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin Exp Allergy. 1999;29(8): 1129-1135.
92. Pariza MW, Ha YL, Benjamin H, Sword JT, Grüter A, Chin SF, Storkson J, Faith N, Albright K. Formation and action of anticarcinogenic fatty acids. Adv Exp Med Biol. 1991;289:269-272.
93. Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 2001;40(4):283-298.
94. Park Y, Albright KJ, Storkson JM, Liu W, Cook ME, Pariza MW. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 1999;34(3):243-248.
95. Parra P, Serra F, Palou A. Moderate doses of conjugated linoleic acid isomers mix contribute to lowering body fat content maintaining insulin sensitivity and a noninflammatory pattern in adipose tissue in mice. J Nutr Biochem. [Epub 2009 Feb 4].
96. Parrish CC, Pathy DA, Angel A. Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism Clin Exp. 1990;39(3):217-219.
97. Parrish CC, Pathy DA, Parkes JG, Angel A. Dietary fish oils modify adipocyte structure and function. J Cell Phys. 1991;148(3):493-502.
98. Pawels EK, Volterrani D. Fatty acid facts, Part I. Essential fatty acids as treatment for depression, or food for mood? Drug News Perspect. 2008;21(8):446-451.
99. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59(10):913-919.
100. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med. 1985;312:1210-1216.
101. Portier K, de Moffarts B, Fellman N, Kirschvink N, Motta C, Letellierw C, Ruelland A, van Erck E, Lekeux P, Couder J. The effects of dietary N-3 and antioxidant supplementation on erythrocyte membrane fatty acid composition and fluidity in exercising horses. Equine Vet J Suppl. 2006;(36):279-284.
102. Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord. 2001;25(8):1129-1135.
103. Rodríguez-Cruz M, Tovar AR, del Prado M, Torres N. Molecular mechanisms of action and health benefits of polyunsaturated fatty acids. Rev Invest Clin. 2005;57(3):457-472.
104. Sanders TA. Polyunsaturated fatty acids in the food chain in Europe. Am J Clin Nutr. 2000;71(1 Suppl):176S-178S.
105. Schirmer MA, Phinney SD. {gamma}-Linolenate reduces weight regain in formerly obese humans. J Nutr. 2007;137(6):1430-1435.
106. Schmidt GR. Therapeutics of fish oil. Abstract of Meeting Presentation. ASHP Annual Meeting 1989;46:1-33.
107. Shahidi F, Miraliakbari H. Omega-3 (n-3) fatty acids in health and disease: Part 1-cardiovascular disease and cancer. J Med Food. 2004;7(4):387-401.
108. Shapira N, Weill P, Loewenbach R. Egg fortification with n-3 polyunsaturated fatty acids (PUFA): nutritional benefits versus high n-6 PUFA western diets, and consumer acceptance. Isr Med Assoc J. 2008;10(4):262-265.
109. Shultz TD, Chew BP, Seaman WR, Luedecke LO. Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells. Cancer Lett. 1992;63(2):125-133.
110. Siddiqui RA, Shaikh SR, Sech LA, Yount HR, Stillwell W, Zaloga GP. Omega 3-fatty acids: health benefits and cellular mechanisms of action. Mini Rev Med Chem. 2004;4(8):859-871.
111. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70(3):560S-569S.
112. Simopoulos AP. Human requirement for N-3 polyunsaturated fatty acids. Poult Sci. 2000;79(7):961-970.
113. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505.
114. Simopoulos AP. The importance of the omega-6(omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008;233(6):674-688.
115. Simopoulos AP. Omega-6(omega-3 essential Fatty acids: biological effects. World Rev Nutr Diet. 2009;99:1-16. [Epub 2009 Jan 9].
116. Sioen I, Huybrechts I, Verbeke W, Camp JV, De Henauw S. n-6 and n-3 PUFA intakes of pre-school children in Flanders, Belgium. Br J Nutr. 2007;98(4):819-825.
117. Sioen I, Matthys C, De Backer G, Van Camp J, Henauw SD. Importance of seafood as nutrient source in the diet of Belgian adolescents. J Hum Nutr Diet. 2007;20(6):580-589.
118. Sioen IA, Pynaert I, Matthys C, De Backer G, Van Camp J, De Henauw S. Dietary intakes and food sources of fatty acids for Belgian women, focused on n-6 and n-3 polyunsaturated fatty acids. Lipids. 2006;41(5):415-422.
119. Smith RS. The cytokine theory of headache. Med Hypotheses. 1992;39(2):168-174.
120. Song C, Li X, Leonard BE, Horrobin DF. Effects of dietary n-3 or n-6 fatty acids on interleukin-lbeta-induced anxiety, stress, and inflammatory responses in rats. J Lipid Res. 2003;44(10):1984-1991.
121. Stahl LA, Begg DP, Weisinger RS, Sinclair AJ. The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs. 2008;9(l):57-64.
122. Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. J Nutr. 2007;137(5):1188-1193.
123. Su KP. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'Mind-Body Interface'? Neurosignals. 2009;17(2):144-152. [Epub 2009 Feb 4].
124. Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind placebo-controlled trial. Eur Neuropsychophar-macol. 2003;13:267-271.
125. Tarnopolsky MA, Safdar A. The potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults. Appl Physiol Nutr Metab. 2008;33(l):213-227.
126. Tassoni D, Kaur G, Weisinger RS, Sinclair AJ. The role of eicosanoids in the brain. Asia Pac J Clin Nutr. 2008;17(Suppl l):220-228.
127. Tate G, Mandell BF, Laposata M, Ohliger D, Baker DG, Schumacher HR, Zurier RB. Suppression of acute and chronic inflammation by dietary gamma linolenic acid. J Rheumatol. 1989;16(6):729-734.
128. Tidow-Kebritchi S, Mobarhan S. Effects of diets containing fish oil and vitamin E on rheumatoid arthritis. Nutr Rev. 200l;59(10):335-338.
129. Tipoe GL, Leung TM, Hung MW, Fung ML. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets. 2007;7(2): 135-144.
130. Trebble TM, Wootton SA, Miles EA, Mullee M, Arden NK, Ballinger AB, Stroud MA, Burdge GC, Calder PC. Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am J Clin Nutr. 2003;78:376-382.
131. Trocki O, Heyd TJ, Waymack JP, Alexander JW. Effects of fish oil on postburn metabolism and immunity. J Parent Enter Nutr. 1987;11:521-528.
132. Walser B, Stebbins CL. Omega-3 fatty acid supplementation enhances stroke volume and cardiac output during dynamic exercise. Eur J Appl Physiol. 2008;104(3):455-461 [Epub 2008 Jun 18].
133. Watkins BA, Li Y, Lippman HE, Seifert MF. Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med (Maywood). 2001;226(6):485-497.
134. Whalley LJ, Fox HC, Wahle KW, Starr JM, Deary U. Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am J Clin Nutr. 2004;80(6): 1650-1657.
135. Yu Y, Correll PH, Vanden Heuvel JP. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim Biophys Acta. 2002;1581(3):89-99.
136. Zulet MA, Marti A, Parra MD, Martinez JA. Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health. J Physiol Biochem. 2005;61(3):483-494.